Aggressive prostate cancer phenotype and genome-wide association studies: where are we now?

Abstract excerpt

The majority of prostate cancer (PCa) is indolent, however, a percentage of patients are initially diagnosed with metastatic disease, for which there is a worse prognosis. There is a lack of biomarkers to identify men at greater risk for developing aggressive PCa. Genome-wide association studies (GWAS) scan the genome to search associations of SNPs with specific traits, like cancer. To date, eight GWAS have...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Disease Progression
• Share to Genetic Variation
• Share to Genome-Wide Association Study